M.E. Icaza-Chávez

Review of the scientific evidence and technical opinion on noncaloric sweetener consumption in gastrointestinal diseases

Nallely Bueno-Hernández, R. Vázquez-Frías, A.T. Abreu y Abreu et al. · Revista de Gastroenterología de México (English Edition) · 2019 · 27 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort

Bryan Adrián Priego-Parra, Sara Alejandra Reyes-Diaz, Héctor Ricardo Ordaz‐Alvarez et al. · Clinics and Research in Hepatology and Gastroenterology · 2024 · 24 citations

Medicine, Molecular Medicine, Molecular Diagnostics +13

Is the Sars‐CoV‐2 virus a possible trigger agent for the development of achalasia?

Janette Furuzawa‐Carballeda, M.E. Icaza-Chávez, Diana Aguilar‐León et al. · Neurogastroenterology & Motility · 2022 · 22 citations · Full text

Life Sciences, Immunology, Pathology +15

Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study

Raúl Bernal-Reyes, M.E. Icaza-Chávez, Luis Alberto Chi‐Cervera et al. · Revista de Gastroenterología de México (English Edition) · 2022 · 21 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Hepatic Steatosis Index (HSI): A Valuable Biomarker in Subjects with Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

Bryan Adrián Priego-Parra, Arturo Triana‐Romero, Génesis Patricia Martínez-Pérez et al. · Annals of Hepatology · 2024 · 19 citations · Full text

Medicine, Endocrinology, Clinical Nutrition +16